Do Anti-SARS-CoV-2 Monoclonal Antibodies Have an Impact on Pregnancy Outcome? A Systematic Review and Meta-Analysis

Monoclonal antibodies (mAbs) have been used as a rescue strategy for pregnant women affected by COVID-19. To explore its impact on maternal-fetal health, we included all observational studies reporting maternal, fetal, delivery and neonatal outcomes in women who underwent mAbs infusion for COVID-19. Primary outcome was the percentage of preterm delivery. We used meta-analyses of proportions to combine data for maternal, fetal, delivery and neonatal outcome of women treated with mAbs for COVID-19 and reported pooled proportions and their 95% confidence intervals (CIs) for categorical variables or mean difference (MD) with their 95% confidence intervals for continuous variables. Preterm birth was observed in 22.8% of cases (95% CI 12.9–34.3). Fetal distress was reported in 4.2% (95% CI 1.6–8.2). Gestational hypertension and pre-eclampsia were observed in 3.0% (95% CI 0.8–6.8) and 3.4% (95% CI 0.8–7.5) of cases, respectively. Fetal growth restriction was observed in 3.2% of fetuses (95% CI 0.8–7.0). Secondary prophylaxis with mAbs is currently considered the best treatment option for people with mild to moderate COVID-19 disease. More attention should be paid to infants born from mothers who were treated with mAbs, for the risk of immunosuppression.

[1]  A. Sørensen,et al.  Risk factors for and pregnancy outcomes after SARS‐CoV‐2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS‐CoV‐2 diagnosis , 2023, Acta obstetricia et gynecologica Scandinavica.

[2]  M. Guida,et al.  Trends in Caesarean Section Rate According to Robson Group Classification among Pregnant Women with SARS-CoV-2 Infection: A Single-Center Large Cohort Study in Italy , 2022, Journal of clinical medicine.

[3]  F. Sellebjerg,et al.  Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis , 2022, European journal of neurology.

[4]  J. Pruszynski,et al.  Examining the impact of trimester of diagnosis on COVID-19 disease progression in pregnancy , 2022, American Journal of Obstetrics & Gynecology MFM.

[5]  H. Minkoff,et al.  Changes in obstetrical practices during the 2020 COVID-19 pandemic , 2022, American Journal of Obstetrics & Gynecology MFM.

[6]  G. Saade,et al.  First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes , 2022, American Journal of Obstetrics and Gynecology.

[7]  J. Meek,et al.  Characteristics and treatment of hospitalized pregnant women with COVID-19 , 2022, American Journal of Obstetrics & Gynecology MFM.

[8]  G. Chodick,et al.  Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study , 2022, PloS one.

[9]  L. Carbone,et al.  COVID‐19 vaccine and pregnancy outcomes: A systematic review and meta‐analysis , 2022, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[10]  A. Al-Harrasi,et al.  Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches , 2022, Biomolecules.

[11]  Hiroaki Tanaka,et al.  Evaluation of the tolerability of monoclonal antibody therapy for pregnant patients with COVID‐19 , 2022, The journal of obstetrics and gynaecology research.

[12]  Kirk A Easley,et al.  Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemic , 2022, American Journal of Obstetrics & Gynecology MFM.

[13]  S. Kazani,et al.  Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series , 2022, American journal of reproductive immunology.

[14]  G. Rizzo,et al.  Systematic review and critical evaluation of quality of clinical practice guidelines on the management of SARS-CoV-2 infection in pregnancy , 2022, American Journal of Obstetrics & Gynecology MFM.

[15]  P. Nowak,et al.  Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy , 2022, Infection.

[16]  H. Hartung,et al.  Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management , 2022, Neurotherapeutics.

[17]  A. Bartoloni,et al.  Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy , 2022, Infection.

[18]  H. Young,et al.  COVID-19 vaccination among pregnant people in the United States: a systematic review , 2022, American Journal of Obstetrics & Gynecology MFM.

[19]  T. Hondo,et al.  Vaginal delivery after improvement in COVID-19 by monoclonal antibody treatment: A case report and literature review , 2022, Journal of Infection and Chemotherapy.

[20]  M. A. Al Hakim,et al.  Sotrovimab Use for COVID-19 Infection in Pregnant Kidney Transplant Recipient. , 2022, Transplantation.

[21]  E. Whittaker,et al.  Use of single-dose tocilizumab for treatment of severe COVID-19 in pregnancy: implications for the timing of live infant vaccines , 2022, Archives of Disease in Childhood.

[22]  Y. Afshar,et al.  Neutralizing Monoclonal Antibodies for Coronavirus Disease 2019 (COVID-19) in Pregnancy , 2022, Obstetrics and gynecology.

[23]  E. Schleußner,et al.  Monoclonal SARS-CoV-2 Antibodies in Pregnancy-a Case Series. , 2022, Deutsches Ärzteblatt International.

[24]  R. Hurt,et al.  Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) , 2022, Obstetrics and gynecology.

[25]  P. Bernstein,et al.  A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy , 2022, American Journal of Obstetrics and Gynecology.

[26]  M. Landray,et al.  Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial , 2021, medRxiv.

[27]  G. Rizzo,et al.  Worldwide beliefs among pregnant women on SARS-CoV-2 vaccine: a systematic review , 2021, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[28]  G. Castaldo,et al.  Invasive prenatal diagnosis during COVID-19 pandemic , 2021, Archives of Gynecology and Obstetrics.

[29]  M. Naqvi,et al.  Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Coronavirus Disease 2019 (COVID-19) , 2021, Obstetrics and gynecology.

[30]  M. Guida,et al.  Obstetric A&E unit admission and hospitalization for obstetrical management during COVID-19 pandemic in a third-level hospital of southern Italy , 2021, Archives of Gynecology and Obstetrics.

[31]  Shazia Abdullah,et al.  Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports , 2021, Journal of Medical Case Reports.

[32]  A. Odibo,et al.  Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report , 2021, American Journal of Obstetrics and Gynecology.

[33]  S. Lapinsky,et al.  Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review , 2021, Clinical Microbiology and Infection.

[34]  A. Khalil,et al.  Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis , 2021, American Journal of Obstetrics & Gynecology MFM.

[35]  P. Bruzzi,et al.  Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) , 2021, Infectious Diseases and Therapy.

[36]  K. Top,et al.  The use and impact of monoclonal antibody biologics during pregnancy , 2021, Canadian Medical Association Journal.

[37]  R. Vallone,et al.  The negative impact of most relevant infections on fertility and Assisted Reproduction Technology. , 2021, Minerva obstetrics and gynecology.

[38]  Z. Williams,et al.  COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women , 2021, American Journal of Obstetrics & Gynecology MFM.

[39]  G. Rizzo,et al.  Women perception of SARS-CoV-2 vaccination during pregnancy and subsequent maternal anxiety: a prospective observational study , 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[40]  G. Rizzo,et al.  Pregnant women perspectives on SARS-COV-2 vaccine Condensation: Most of Italian pregnant women would not agree to get the SARS-COV-2 vaccine, irrespective of having features of high risk themselves, or being high-risk pregnancies. , 2021, American Journal of Obstetrics & Gynecology MFM.

[41]  M. Miarons,et al.  Safety of tocilizumab in COVID‐19 pregnant women and their newborn: A retrospective study , 2021, Journal of clinical pharmacy and therapeutics.

[42]  Taisuke Mori,et al.  Severe coronavirus disease pneumonia in a pregnant woman at 25 weeks' gestation: A case report , 2021, The journal of obstetrics and gynaecology research.

[43]  John D. Davis,et al.  REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 , 2020, The New England journal of medicine.

[44]  A. Esmaeilzadeh,et al.  COVID‐19: Virology, biology and novel laboratory diagnosis , 2020, The journal of gene medicine.

[45]  R. Vallone,et al.  IVF during Coronavirus pandemic: who comes first? The POSEIDON viewpoint , 2020 .

[46]  M. Dubinsky,et al.  Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease. , 2020, Gastroenterology.

[47]  L. Carbone,et al.  Proposal for radiologic diagnosis and follow-up of COVID-19 in pregnant women , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[48]  M. Naqvi,et al.  Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19). , 2020, Obstetrics and gynecology.

[49]  Fabiola C. Bento,et al.  COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management , 2020, Reproductive Biology and Endocrinology.

[50]  J. Biggio,et al.  Society for Maternal-Fetal Medicine (SMFM) Consult Series #50: The role of activity restriction in obstetric management. , 2020, American journal of obstetrics and gynecology.

[51]  M. Gissler,et al.  Anti‐TNF treatment during pregnancy and birth outcomes: A population‐based study from Denmark, Finland, and Sweden , 2020, Pharmacoepidemiology and drug safety.

[52]  K. Top,et al.  From mother to baby: antenatal exposure to monoclonal antibody biologics , 2019, Expert review of clinical immunology.

[53]  M. Murad,et al.  Methodological quality and synthesis of case series and case reports , 2018, BMJ Evidence-Based Medicine.

[54]  Wendy Watson,et al.  Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data , 2016, Vaccine.

[55]  Steven J Brown,et al.  Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. , 2016, Gastroenterology.

[56]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[57]  Mark Loeb,et al.  Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments , 2014, BMC Medical Research Methodology.

[58]  D. Hawks The American College of Obstetricians and Gynecologists (ACOG) , 2014 .

[59]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions : Explanation and Elaboration , 2009 .

[60]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[61]  K. Nicolaides,et al.  Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy , 1996, American journal of reproductive immunology.